Genetic Factors Related with Early Onset of Osteonecrosis of the Jaw in Patients with Multiple Myeloma Under Zoledronic Acid Therapy

被引：0
作者：
Melea, Pelagia [1 ]
Bagratuni, Tina [2 ]
Terpos, Evangelos [2 ]
Eleutherakis-Papaiakovou, Evangelos [2 ]
Gavriatopoulou, Maria [2 ]
Melakopoulos, Ioannis [1 ]
Kastritis, Efstathios [2 ]
Dimopoulos, Meletios A. [2 ]
机构：
[1] Henry Dunant Hosp, Athens, Greece
[2] Univ Athens, Sch Med, Athens 11528, Greece
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Osteonecrosis of the jaw in patients treated with sunitinib and zoledronic acid.
    Bozas, G.
    Allgar, V.
    Greenwood, G.
    Maraveyas, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients
    Melea, Pelagia I.
    Melakopoulos, Ioannis
    Kastritis, Efstathios
    Tesseromatis, Christina
    Margaritis, Vasileios
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    INTERNATIONAL JOURNAL OF DENTISTRY, 2014, 2014
  • [23] Alendronic-acid/zoledronic-acidMedication-related osteonecrosis of the jaw
    Reactions Weekly, 2024, 1991 (1) : 20 - 20
  • [24] Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma
    Badros, Ashraf
    Terpos, Evangelos
    Katodritou, Eirini
    Goloubeva, Olga
    Kastritis, Efstathios
    Verrou, Evgenia
    Zervas, Kostas
    Baer, Maria R.
    Meiller, Timothy
    Dimopoulos, Meletios A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (36) : 5904 - 5909
  • [25] Osteonecrosis of the jaw in multiple myeloma patients receiving bisphosphonates
    Bilalis, A.
    Pouli, A.
    Konstantelos, D.
    Koropoulis, G.
    Stefanitsi, P.
    Sioni, A.
    Papanastasiou, K.
    Tsakanikas, S.
    Rapidis, A.
    Pamouktsoglou, P.
    Michaloudis, G.
    Stamatelou, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 255 - 255
  • [26] OSTEONECROSIS OF THE JAW IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH BISPHOSPHANATES
    Pavkovic, M.
    Petrushevska, G.
    Sotirova, T.
    Trpkovska-Terzieva, S.
    Karanfilski, O.
    Cevreska, L.
    Stankovic, S.
    Stojanovic, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 594 - 594
  • [27] Osteonecrosis of the jaw in multiple myeloma patients (the IFM registry)
    Fuzibet, Jean Gabriel
    Viellard, Marie Helene
    Rossignol, Benoit B. R.
    Doyen, Chantal C. D.
    Hulin, Cyril
    Garderet, Laurent L. G.
    Blanc, Michel M. B.
    Marit, Gerald
    Facon, Thierry T. F.
    Moreau, Philippe
    BLOOD, 2007, 110 (11) : 276B - 276B
  • [28] Multiple Myeloma and IV Bisphosphonate Are Risk Factors for Osteonecrosis of the Jaw
    Tennis, Pat
    Rothman, Kenneth J.
    Bohn, Rhonda
    Tan, Hiangkat
    Anthony, Mary
    Zavras, Athanosios
    Calingaert, Brian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S313 - S314
  • [29] Risk factors for developing osteonecrosis of jaw in advanced cancer patients underwent zoledronic acid treatment
    Qi, Wei-Xiang
    Zhao, Shengguang
    Chen, Jiayi
    FUTURE ONCOLOGY, 2019, 15 (30) : 3503 - 3511
  • [30] Decreased incidence of osteonecrosis of the jaw (ONJ) in patients with multiple myeloma (MM) treated with zoledronic acid (ZA) after application of preventive measures
    Dimopoulos, Meletios Athanasios
    Kastritis, Efstathios
    Bamia, Christina
    Melakopoulos, Ioannis
    Gika, Dimitra
    Roussou, Maria
    Migkou, Magdalini
    Eleutherakis-Papaiakovou, Evangelos
    Bamias, Aristotle
    BLOOD, 2007, 110 (11) : 1056A - 1056A
12345